Robert S Lebovics, MD Email Robert Lebovics
- ASSOCIATE PROFESSOR | Otolaryngology
- Ear, Nose, Throat (ENT) / Otolaryngology
- Hospital Affiliations
- Mount Sinai Morningside and Mount Sinai West
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West 212-262-4444 212-262-4444
Robert S. Lebovics, MD, FACS, is a nationally and internationally known otolaryngologist with expertise in infectious and inflammatory disorders for both adults and children. Dr. Lebovics received his medical degree from the State University of New York Downstate in Brooklyn, NY, and completed otolaryngology training at the Albert Einstein/Montefiore Hospital Medical Center. For almost nine years after his residency, Dr. Lebovics was Chief of the Clinical Otolaryngology Service at the National Institutes of Health in Bethesda, Maryland, working with the National Institute of Deafness and Communication Disorders. At NIH, he interfaced in the medical frontiers of gene therapy, immunotoxins for treating head and neck cancer, and techniques of surgical rehabilitation for both the larynx/trachea and the sinonasal tract. Concurrently, Dr. Lebovics maintained a faculty appointment at Georgetown University where he regularly lectured and taught new physicians.
In 1997, Dr. Lebovics relocated back to his native New York and joined the hospital service that later became the Mount Sinai West (MSW) and Mount Sinai-St. Luke’s (MSSL) Hospitals. Dr. Lebovics has focused his practice on breathing disorders and rehabilitation of the upper airways. As part of his work in moving the art and science of medicine in laryngeal and tracheal repair, he has collaborated with the Department of Thoracic Surgery, performing innovative procedures to rehabilitate and treat upper airway obstructions. Dr. Lebovics, together with Chief of Thoracic Surgery at MSW/MSSL Dr. Faiz Bhora, has worked for several years in the laboratory performing surgery on pigs, implanting bioengineered three-dimensional printed scaffolds to replace the native pig trachea, some of which have been impregnated with lines of stems cells. He continues to be involved in this cutting-edge research, ultimately seeking new techniques of rehabilitating the airway.
Dr. Lebovics is an Associate Professor of Otolaryngology, Head and Neck Surgery at the Icahn School of Medicine of Mount Sinai in NYC. He is a member of various organizations, including being a Fellow of the American College of Surgeons and a Fellow of the American Academy of Otolaryngology - Head and Neck Surgery. He served for two years as the Secretary/Treasurer of the New York Laryngological Society, and currently serves as a police surgeon for the NYPD. He is also on the Medical Advisory Board for the Vasculitis Foundation based in Kansas City, Missouri, where he served on their Board of Directors for six years.
He employs endoscopic techniques in the OR for repair of the larynx, trachea and large bronchi, using balloons, cryotherapy, and injections, as well as implanting stents for both benign and malignant disease. He focuses on autoimmune and inflammatory diseases affecting the upper airways and head and neck region. Some of these diseases include: Wegener's granulomatosis (a.k.a., Granulomatosis with polyangiitis), Churg-Strauss syndrome (a.k.a., Eosinophilic Granulomatosis with polyangiitis), sarcoidosis, relapsing polychondritis, and Sjogren’s Syndrome. Other autoimmune diseases that can affect the head and neck include autoimmune hearing loss, Cogan’s syndrome, immune deficiencies, vasculitis, temporal arteritis, Behcet’s disease, Takayasu arteritis of the head and neck, scleroderma, and dermatomyositis.
Watch his TV appearance on Fox News, “What Killed Harold Ramis?” about vasculitis.
- Aphthous Ulcers
- ENT Consultation
- Laryngeal Spasm
- Sjogren's Syndrome
- Tracheal Stenosis
- Wegener's Granulomatosis
MD, SUNY Downstate Medical Center
Internship, General Surgery
Montefiore Medical Center
Residency, Otolaryngology - Head & Neck Surgery
Montefiore Medical Center
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Lebovics during 2021 and/or 2022. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
Scientific Advisory Board:
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.